Your session is about to expire
← Back to Search
mHealth Peer Support for HIV/AIDS
N/A
Waitlist Available
Led By Kathleen W Page
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
≥ 18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial is testing a new way to help people with HIV keep up with their medical care.
Who is the study for?
This trial is for adults over 18 who have been identified by clinics as needing support services due to a new HIV diagnosis or because they're 'out of care' with their HIV treatment. They must be able to give consent.Check my eligibility
What is being tested?
The study compares traditional patient support services (LTCR) with an enhanced version using mobile health technology (mLTCR) to see if it improves engagement in HIV care for African-Americans and Latinxs.See study design
What are the potential side effects?
Since the interventions involve patient support services and use of mobile health technology, there are no direct medical side effects. However, participants may experience privacy concerns or stress related to technology use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion with HIV Viral Load Suppression (copies/cc)
Secondary outcome measures
Proportion Retained in Care
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: mLTCRExperimental Treatment1 Intervention
The mLTCR intervention consists of two smartphone applications (app), one for patients and one for patient supporters, to help facilitate communication.
Group II: LTCActive Control1 Intervention
Existing linkage to care and retention (LTCR) services which are standard-of-care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
mLTCR
2020
N/A
~450
Find a Location
Who is running the clinical trial?
Patient-Centered Outcomes Research InstituteOTHER
549 Previous Clinical Trials
29,996,328 Total Patients Enrolled
Johns Hopkins UniversityLead Sponsor
2,256 Previous Clinical Trials
14,819,623 Total Patients Enrolled
Kathleen W PagePrincipal InvestigatorJohns Hopkins School of Medicine
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am unable to give consent for medical procedures.
Research Study Groups:
This trial has the following groups:- Group 1: mLTCR
- Group 2: LTC
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still vacancies to participate in this scientific exploration?
"Absolutely. According to clinicaltrials.gov, the recruitment process for this medical study is in full swing - it was first uploaded on February 10th 2020 and recently updated on March 8th 2022. The trial requires 500 participants at a single site."
Answered by AI
How many participants are currently involved in this medical experiment?
"Affirmative. The information on clinicaltrials.gov affirms this study is still open to enrollment and has been since February 10th, 2020. This medical trial requires 500 participants at a single site and was last updated on March 8th 2022."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger